Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001726334-25-000003
Filing Date
2025-09-16
Accepted
2025-09-16 16:15:07
Documents
1
Period of Report
2025-09-12

Document Format Files

Seq Description Document Type Size
1 form4-09162025_040904.html 4  
1 form4-09162025_040904.xml 4 9776
  Complete submission text file 0001726334-25-000003.txt   11458
Mailing Address 575 MADISON AVENUE NEW YORK NY 10022
Business Address 575 MADISON AVENUE NEW YORK NY 10022 917-450-6581
LB PHARMACEUTICALS INC (Issuer) CIK: 0001691082 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address 14 SHENKAR STREET, BEIT OFEK HERZLIYA PITUACH L3 46140
Business Address 14 SHENKAR STREET, BEIT OFEK HERZLIYA PITUACH L3 46140 972-9-9725617
Pontifax Management 4 G.P. (2015) Ltd. (Reporting) CIK: 0001726334 (see all company filings)

State of Incorp.: L3
Type: 4 | Act: 34 | File No.: 001-42831 | Film No.: 251317490